Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Polycystic Ovary Syndrome 10Insulin Resistance 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Prostatic Neoplasms 4Diabetes Mellitus, Type 2 4Pancreatic Neoplasms 3Diabetes Mellitus 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Metabolic Syndrome 2Leukoplakia, Oral 2Leukemia, Myeloid, Chronic-Phase 2Inflammation 2Carotid Intimal Medial Thickness 1 2Breast Neoplasms 2Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene 1Sleep Apnea, Obstructive 1Skin Neoplasms 1Recurrence 1Prostatic Neoplasms, Castration-Resistant 1Pharmacokinetics of MDV3100 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Meningioma 1Memory Disorders 1Lung Neoplasms 1Liposarcoma, Myxoid 1Liposarcoma 1Leukemia, Myeloid, Acute 1

Interventions

Gemcitabine 685130-nm albumin-bound paclitaxel 199Fluorouracil 190Oxaliplatin 177Albumin-Bound Paclitaxel 154Capecitabine 137Leucovorin 133Irinotecan 114Radiotherapy 96Taxes 85pembrolizumab 81Cisplatin 73Erlotinib Hydrochloride 70Radiosurgery 69Nivolumab 56Drug Therapy 56Bevacizumab 54Magnetic Resonance Spectroscopy 51Cyclophosphamide 50folfirinox 45Specimen Handling 43Docetaxel 42Cetuximab 40Biopsy 39irinotecan sucrosofate 38S 1 (combination) 36Pancreaticoduodenectomy 35Blood Specimen Collection 34Surgical Procedures, Operative 31Paclitaxel 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × Pioglitazone × Clear all
NCT01838317 2021-03-01

A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas

University of Texas Southwestern Medical Center

Phase 2 Completed
14 enrolled 8 charts
Gastrointestinal

Pancreatic Neoplasms

NCT00867126 2018-11-26

Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine

University of Texas Southwestern Medical Center

Phase EARLY_PHASE1 Terminated
6 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02475499 2016-03-14

Incretin-based Drugs and Pancreatic Cancer

Canadian Network for Observational Drug Effect Studies, CNODES

Completed
886,172 enrolled
Gastrointestinal

Diabetes Mellitus, Type 2, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡